{"id":"HHS-OASH-2026-0397-2802","name":"","organization":"Rocky Mountains for Safe Technology, Susan Foster, CEO","posted":"2026-10-14T04:00Z","received":"2026-10-11T04:00Z","body":"See comment attached. \n\n*See attached additional Electromagnetic Field Studies demonstrating harmful effects published since 2019.  \n\nSusan Foster, CEO\nRocky Mountains for Safe Technology\nEmail: susan.foster04@gmail.com","source_hash":"8739576f368dc1bacabab9d536ca265b040741f05b782281560384ad3fa3ae24","filing_type":"","proceedings":"","captured_at":"","source_name":"","number":"2802","withheld":false,"attachment_inventory":true,"capture_reviewed":false,"source":"https://www.regulations.gov/comment/HHS-OASH-2026-0397-2802","slug":"research-evidence-comment-2802","tags":[],"attachments":["https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_4.pdf","https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_1.pdf","https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_2.pdf","https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_3.pdf"],"attachment_names":{"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_4.pdf":"Enhanced Brain Clearance of Tau and Amyloid in Alzheimer's Disease Patients by Transcranial Radiofrequency Wave Treatment A Central Role of Vascular Endothelial Growth Factor VEGF","https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_1.pdf":"RMST HHS Comments 2019 Studies 10-2026","https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_2.pdf":"Elucidation of a non thermal mechanism for DNA RNA fragmentation and protein degradation when using Lyse It","https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_3.pdf":"EM b61 276"},"classification":null,"supplied_classification":null,"attachment_metadata":{"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_4.pdf":{"title":"Enhanced Brain Clearance of Tau and Amyloid in Alzheimer's Disease Patients by Transcranial Radiofrequency Wave Treatment A Central Role of Vascular Endothelial Growth Factor VEGF","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_4.pdf","upstream_key":"161d8295240968938630ea16fa83747c5c990aec35f9084581deecfebd3e8ff7","key":"161d8295240968938630ea16fa83747c5c990aec35f9084581deecfebd3e8ff7"},"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_1.pdf":{"title":"RMST HHS Comments 2019 Studies 10-2026","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_1.pdf","upstream_key":"640ec44a0f72c13b09aac16e6a2c91b6c3d13063b836e0b5ef50c34b1513a26b","key":"640ec44a0f72c13b09aac16e6a2c91b6c3d13063b836e0b5ef50c34b1513a26b"},"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_2.pdf":{"title":"Elucidation of a non thermal mechanism for DNA RNA fragmentation and protein degradation when using Lyse It","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_2.pdf","upstream_key":"87a47be90f666d2732368939cd2550b4e6e484773571052803f86e2fd986fd8d","key":"87a47be90f666d2732368939cd2550b4e6e484773571052803f86e2fd986fd8d"},"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_3.pdf":{"title":"EM b61 276","mime":"application/pdf","source":"https://downloads.regulations.gov/HHS-OASH-2026-0397-2802/attachment_3.pdf","upstream_key":"f70f856899003281feb52577c31686c57c9f199f2d3e0ee93550786e487f9b69","key":"f70f856899003281feb52577c31686c57c9f199f2d3e0ee93550786e487f9b69"}},"mirror_fingerprint":"9ccdd623bd8df0c5e846e85faa3fa4ffe8f1d76273230d2ba4cb9024370e5031","seo_modified":"2026-10-29T15:28:52Z","forum_topics":["awaiting-review"],"primary_topic":"awaiting-review","forum_title":"See comment attached. *See attached additional Electromagnetic Field Studies demonstrating harmful effect…"}